'Early treatment' breakthrough in HIV research

Early antiretroviral therapy reduces HIV transmission by 96%, Wits University announced on Thursday, following a multi-centre study.

Professors provoke breastfeeding outrage

UKZN researchers argue that government clinics should stop providing free formula milk to all HIV-infected mothers.

Civil society: Health

Naeemah Abrahams, Miriam Adhikari, Carol-Ann Benn, Francesca Conradie, Lynette Denny, Sharon Ekambaram, Sharon Fonn and more ...

SA HIV vaccines on brink of human testing

Researchers from the University of Cape Town have developed two test HIV vaccines -- the first wholly South African-developed products to enter the human clinical-trials phase, the Herald Online reported on Tuesday. The vaccines are just months away from being assessed in human clinical trials, the report said.

HIV vaccine trials in SA put on hold

All HIV vaccine trials in South Africa have been put on hold following the failure of the Phambili trial. Health Minister Manto Tshabalala-Msimang on Wednesday invited researchers who worked on the Phambili study to her office in Pretoria to explain the reasons why the vaccine trial was stopped.

Huge disappointment as HIV vaccine trial ends

The supervisor of a major HIV vaccine trial in South Africa voiced "huge disappointment" on Saturday after testing was halted in the wake of poor results from sister trials in Australia and the United States. US pharmaceutical giant Merck announced on Friday that it had halted the trials of its V520 vaccine.

Promising HIV vaccine trial halted in SA

A major HIV vaccine trial in South Africa was brought to a halt on Friday after interim results from a sister trial in the United States and Australia suggested it failed to prevent HIV infection. The news came as a major blow to Aids researchers as the vaccine had been billed as the world's most promising Aids-vaccine candidate.

Preliminary trial results encouraging for HIV vaccines

Parallel trials for Aids vaccines in South Africa look promising in their long road to conclusion, a press conference in Sandton heard on Friday. Indications are that vaccine trials tailored for global strains had an effect against the strain of the virus most prevalent in South Africa.

IN THIS WEEK'S PAPER

Sponsored links

	Business travel experts		Flowers & gifts
	Domestic & Regional Airline		Bulk SMS gateway